159 related articles for article (PubMed ID: 23410746)
1. The association of oxidative stress markers with conventional risk factors in the metabolic syndrome.
Korkmaz GG; Altınoglu E; Civelek S; Sozer V; Erdenen F; Tabak O; Uzun H
Metabolism; 2013 Jun; 62(6):828-35. PubMed ID: 23410746
[TBL] [Abstract][Full Text] [Related]
2. Advanced oxidation protein products are more related to metabolic syndrome components than biomarkers of lipid peroxidation.
Venturini D; Simão AN; Dichi I
Nutr Res; 2015 Sep; 35(9):759-65. PubMed ID: 26255193
[TBL] [Abstract][Full Text] [Related]
3. Association of serum lycopene and brachial-ankle pulse wave velocity with metabolic syndrome.
Yeo HY; Kim OY; Lim HH; Kim JY; Lee JH
Metabolism; 2011 Apr; 60(4):537-43. PubMed ID: 20580031
[TBL] [Abstract][Full Text] [Related]
4. DNA damage in metabolic syndrome and its association with antioxidative and oxidative measurements.
Demirbag R; Yilmaz R; Gur M; Celik H; Guzel S; Selek S; Kocyigit A
Int J Clin Pract; 2006 Oct; 60(10):1187-93. PubMed ID: 16981963
[TBL] [Abstract][Full Text] [Related]
5. Association of metabolic syndrome risk factors with selected markers of oxidative status and microinflammation in healthy omnivores and vegetarians.
Sebeková K; Boor P; Valachovicová M; Blazícek P; Parrák V; Babinská K; Heidland A; Krajcovicová-Kudlácková M
Mol Nutr Food Res; 2006 Sep; 50(9):858-68. PubMed ID: 16917805
[TBL] [Abstract][Full Text] [Related]
6. Association between C-reactive protein, pro-oxidant-antioxidant balance and traditional cardiovascular risk factors in an Iranian population.
Razavi A; Baghshani MR; Rahsepar AA; Mohaddes Ardabili H; Sheikh Andalibi MS; Reza Parizadeh SM; Tavallaie S; Mousavi S; Ghayour-Mobarhan M; Ferns G
Ann Clin Biochem; 2013 Mar; 50(Pt 2):115-21. PubMed ID: 23440541
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of oxidative stress in overweight subjects with or without metabolic syndrome.
Venturini D; Simão AN; Scripes NA; Bahls LD; Melo PA; Belinetti FM; Lozovoy MA; Dichi I
Obesity (Silver Spring); 2012 Dec; 20(12):2361-6. PubMed ID: 22592332
[TBL] [Abstract][Full Text] [Related]
8. Association between serum uric acid, high sensitive C-reactive protein and pro-oxidant-antioxidant balance in patients with metabolic syndrome.
Ahmadnezhad M; Arefhosseini SR; Parizadeh MR; Tavallaie S; Tayefi M; Darroudi S; Ghazizadeh H; Moohebati M; Ebrahimi M; Heidari-Bakavoli A; Azarpajouh MR; Ferns GA; Mogharebzadeh V; Ghayour-Mobarhan M
Biofactors; 2018 May; 44(3):263-271. PubMed ID: 29638023
[TBL] [Abstract][Full Text] [Related]
9. Role of metabolic syndrome and antiretroviral therapy in adiponectin levels and oxidative stress in HIV-1 infected patients.
Morimoto HK; Simão AN; de Almeida ER; Ueda LT; Oliveira SR; de Oliveira NB; Petenucci DL; Panis C; Cecchini R; Dichi I; Reiche EM
Nutrition; 2014; 30(11-12):1324-30. PubMed ID: 25280407
[TBL] [Abstract][Full Text] [Related]
10. Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease.
Altunoglu E; Guntas G; Erdenen F; Akkaya E; Topac I; Irmak H; Derici H; Yavuzer H; Gelisgen R; Uzun H
Geriatr Gerontol Int; 2015 Jul; 15(7):872-80. PubMed ID: 25345484
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.
Utzschneider KM; Van de Lagemaat A; Faulenbach MV; Goedecke JH; Carr DB; Boyko EJ; Fujimoto WY; Kahn SE
Obesity (Silver Spring); 2010 Sep; 18(9):1781-7. PubMed ID: 20379148
[TBL] [Abstract][Full Text] [Related]
12. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
13. Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome.
Guerrero-Romero F; Rodríguez-Morán M
Diabetes Metab Res Rev; 2006; 22(6):471-6. PubMed ID: 16598698
[TBL] [Abstract][Full Text] [Related]
14. Elevated advanced oxidation protein products (AOPPs) indicate metabolic risk in severely obese children.
Codoñer-Franch P; Tavárez-Alonso S; Murria-Estal R; Tortajada-Girbés M; Simó-Jordá R; Alonso-Iglesias E
Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):237-43. PubMed ID: 20708392
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress.
Helal O; Defoort C; Robert S; Marin C; Lesavre N; Lopez-Miranda J; Risérus U; Basu S; Lovegrove J; McMonagle J; Roche HM; Dignat-George F; Lairon D
Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):665-71. PubMed ID: 20399083
[TBL] [Abstract][Full Text] [Related]
16. Differences in the behavior of advanced glycation end products and advanced oxidation protein products in patients with allergic rhinitis.
Di Lorenzo G; Minciullo PL; Leto-Barone MS; La Piana S; La Porta G; Saija A; Gangemi S
J Investig Allergol Clin Immunol; 2013; 23(2):101-6. PubMed ID: 23654076
[TBL] [Abstract][Full Text] [Related]
17. Advanced oxidation protein products, total thiol levels and total oxidant/antioxidant status in patients with nash.
Başkol M; Dolbun Seçkin K; Başkol G
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():32-7. PubMed ID: 25910362
[TBL] [Abstract][Full Text] [Related]
18. Enhanced oxidative stress and platelet activation combined with reduced antioxidant capacity in obese prepubertal and adolescent girls with full or partial metabolic syndrome.
Karamouzis I; Pervanidou P; Berardelli R; Iliadis S; Papassotiriou I; Karamouzis M; Chrousos GP; Kanaka-Gantenbein C
Horm Metab Res; 2011 Aug; 43(9):607-13. PubMed ID: 21823055
[TBL] [Abstract][Full Text] [Related]
19. Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls.
Neri S; Signorelli SS; Torrisi B; Pulvirenti D; Mauceri B; Abate G; Ignaccolo L; Bordonaro F; Cilio D; Calvagno S; Leotta C
Clin Ther; 2005 Nov; 27(11):1764-73. PubMed ID: 16368447
[TBL] [Abstract][Full Text] [Related]
20. Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered.
Torun AN; Vural M; Cece H; Camuzcuoglu H; Toy H; Aksoy N
Gynecol Endocrinol; 2011 Dec; 27(12):988-92. PubMed ID: 21557696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
